Bergeron Eric, Vincent Martin J, Wickham Louise, Hamelin Josée, Basak Ajoy, Nichol Stuart T, Chrétien Michel, Seidah Nabil G
Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, Montreal, Que., Canada H2W 1R7.
Biochem Biophys Res Commun. 2005 Jan 21;326(3):554-63. doi: 10.1016/j.bbrc.2004.11.063.
Severe acute respiratory syndrome coronavirus (SARS-CoV) is the etiological agent of SARS. Analysis of SARS-CoV spike glycoprotein (S) using recombinant plasmid and virus infections demonstrated that the S-precursor (proS) exists as a approximately 190 kDa endoplasmic reticulum form and a approximately 210 kDa Golgi-modified form. ProS is subsequently processed into two C-terminal proteins of approximately 110 and approximately 80 kDa. The membrane-bound proprotein convertases (PCs) furin, PC7 or PC5B enhanced the production of the approximately 80 kDa protein. In agreement, proS processing, cytopathic effects, and viral titers were enhanced in recombinant Vero E6 cells overexpressing furin, PC7 or PC5B. The convertase inhibitor dec-RVKR-cmk significantly reduced proS cleavage and viral titers of SARS-CoV infected cells. In addition, inhibition of processing by dec-RVKR-cmk completely abrogated the virus-induced cellular cytopathicity. A fluorogenically quenched synthetic peptide encompassing Arg(761) of the spike glycoprotein was efficiently cleaved by furin and the cleavage was inhibited by EDTA and dec-RVKR-cmk. Taken together, our data indicate that furin or PC-mediated processing plays a critical role in SARS-CoV spread and cytopathicity, and inhibitors of the PCs represent potential therapeutic anti-SARS-CoV agents.
严重急性呼吸综合征冠状病毒(SARS-CoV)是SARS的病原体。利用重组质粒和病毒感染对SARS-CoV刺突糖蛋白(S)进行分析表明,S前体(proS)以约190 kDa的内质网形式和约210 kDa的高尔基体修饰形式存在。ProS随后被加工成两个C末端蛋白,大小约为110 kDa和约80 kDa。膜结合的前蛋白转化酶(PCs)弗林蛋白酶、PC7或PC5B可增强约80 kDa蛋白的产生。同样,在过表达弗林蛋白酶、PC7或PC5B的重组Vero E6细胞中,proS加工、细胞病变效应和病毒滴度均增强。转化酶抑制剂dec-RVKR-cmk可显著降低SARS-CoV感染细胞的proS切割和病毒滴度。此外,dec-RVKR-cmk对加工的抑制完全消除了病毒诱导的细胞病变。包含刺突糖蛋白Arg(761)的荧光淬灭合成肽可被弗林蛋白酶有效切割,且切割受到EDTA和dec-RVKR-cmk的抑制。综上所述,我们的数据表明,弗林蛋白酶或PC介导的加工在SARS-CoV传播和细胞病变中起关键作用,PCs抑制剂代表了潜在的抗SARS-CoV治疗药物。